Market revenue in 2023 | USD 60.8 million |
Market revenue in 2030 | USD 159.3 million |
Growth rate | 14.8% (CAGR from 2023 to 2030) |
Largest segment | Biorepository services |
Fastest growing segment | Biorepository Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biorepository Services, Archiving Solution Services |
Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Biorepository services was the largest segment with a revenue share of 66.45% in 2023. Horizon Databook has segmented the Japan clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is a major potential destination for biopharmaceuticals and global CROs due to advancements in technology, policy reforms, faster recruitment of patients, and presence of a developed R&D infrastructure.
These factors are expected to drive clinical research, which is expected to lead to increase in the demand for efficient clinical trial biorepository & archiving solutions, thereby propelling growth of clinical trial biorepository & archiving solutions market in this country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account